ELAN insider transaction filings

Elanco Animal Health Inc — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-21. Screen ELAN transaction legs live →

FiledFormInsiderReported transactionsSource
2026-08-214Kurzius Lawrence Erik — DirectorPurchase (P): 40,000 @ $23.40EDGAR
2026-08-184O'Neill Shiv — GC AND CORP SECPurchase (P): 3,998 @ $23.58EDGAR
2026-08-134Harrington Michael J — DirectorPurchase (P): 5,000 @ $21.82EDGAR
2026-08-104Herendeen Paul — DirectorPurchase (P): 10,000 @ $23.68EDGAR
2026-08-104Modi Rajeev A. — SEE REMARKSGrant/award (A): 66.77 (derivative) @ $22.12EDGAR
2026-08-104VanHimbergen Robert M — EVP and CFOPurchase (P): 4,200 @ $23.08 · Grant/award (A): 8.91 (derivative) @ $22.12EDGAR
2026-08-104Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, DirectorGrant/award (A): 127.80 (derivative) @ $22.12EDGAR
2026-07-284Modi Rajeev A. — SEE REMARKSGrant/award (A): 59.29 (derivative) @ $24.91EDGAR
2026-07-284Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, DirectorGrant/award (A): 113.49 (derivative) @ $24.91EDGAR
2026-07-284VanHimbergen Robert M — EVP and CFOGrant/award (A): 7.91 (derivative) @ $24.91EDGAR
2026-07-144Modi Rajeev A. — SEE REMARKSGrant/award (A): 59.51 (derivative) @ $24.82EDGAR
2026-07-144VanHimbergen Robert M — EVP and CFOGrant/award (A): 7.94 (derivative) @ $24.82EDGAR
2026-07-144Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, DirectorGrant/award (A): 113.90 (derivative) @ $24.82EDGAR
2026-07-094VanHimbergen Robert M — EVP and CFOTax withholding (F): 15,336 @ $24.64EDGAR
2026-07-024Kinard David S — SEE REMARKSGrant/award (A): 25,620 (derivative) @ $0EDGAR
2026-07-024Anand Kapila K — DirectorGrant/award (A): 584.11 (derivative) @ $24.61EDGAR
2026-06-304Modi Rajeev A. — SEE REMARKSGrant/award (A): 60.11 (derivative) @ $24.57EDGAR
2026-06-304VanHimbergen Robert M — EVP and CFOGrant/award (A): 8.02 (derivative) @ $24.57EDGAR
2026-06-304Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, DirectorGrant/award (A): 115.06 (derivative) @ $24.57EDGAR
2026-06-164Modi Rajeev A. — SEE REMARKSGrant/award (A): 61.11 (derivative) @ $24.17EDGAR
2026-06-164VanHimbergen Robert M — EVP and CFOGrant/award (A): 8.15 (derivative) @ $24.17EDGAR
2026-06-164Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, DirectorGrant/award (A): 116.96 (derivative) @ $24.17EDGAR
2026-06-024Modi Rajeev A. — SEE REMARKSGrant/award (A): 61.93 (derivative) @ $23.85EDGAR
2026-06-024VanHimbergen Robert M — EVP and CFOGrant/award (A): 8.26 (derivative) @ $23.85EDGAR
2026-06-024Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, DirectorGrant/award (A): 118.53 (derivative) @ $23.85EDGAR
2026-05-264Ma Stacey — DirectorGrant/award (A): 4,678 @ $0 · Grant/award (A): 12,196 @ $0EDGAR
2026-05-264Anand Kapila K — DirectorGrant/award (A): 4,678 @ $0 · Grant/award (A): 12,196 @ $0EDGAR
2026-05-264Harrington Michael J — DirectorGrant/award (A): 4,678 @ $0 · Grant/award (A): 12,196 @ $0EDGAR
2026-05-264McDonald Kirk P — DirectorGrant/award (A): 4,678 @ $0 · Grant/award (A): 12,196 @ $0EDGAR
2026-05-264Kochevar Deborah Turner — DirectorGrant/award (A): 4,678 @ $0EDGAR
2026-05-264Herendeen Paul — DirectorGrant/award (A): 4,678 @ $0 · Grant/award (A): 12,196 @ $0EDGAR
2026-05-264Kurzius Lawrence Erik — DirectorGrant/award (A): 4,678 @ $0 · Grant/award (A): 12,196 @ $0EDGAR
2026-05-264Scots-Knight Denise — DirectorGrant/award (A): 4,678 @ $0 · Grant/award (A): 12,196 @ $0EDGAR
2026-05-264HOOVER R DAVID — DirectorGrant/award (A): 4,678 @ $0EDGAR
2026-05-264GARCIA ART A — DirectorGrant/award (A): 4,678 @ $0 · Grant/award (A): 12,196 @ $0EDGAR
2026-05-194Modi Rajeev A. — SEE REMARKSPurchase (P): 4,911 @ $20.35 · Grant/award (A): 74.37 (derivative) @ $19.86EDGAR
2026-05-194VanHimbergen Robert M — EVP and CFOGrant/award (A): 9.92 (derivative) @ $19.86EDGAR
2026-05-194Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, DirectorPurchase (P): 4,971 @ $20.09 · Grant/award (A): 142.34 (derivative) @ $19.86EDGAR
2026-05-054Modi Rajeev A. — SEE REMARKSGrant/award (A): 65.61 (derivative) @ $22.51EDGAR
2026-05-054VanHimbergen Robert M — EVP and CFOGrant/award (A): 8.75 (derivative) @ $22.51EDGAR
2026-05-054Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, DirectorGrant/award (A): 125.59 (derivative) @ $22.51EDGAR
2026-04-214Modi Rajeev A. — SEE REMARKSGrant/award (A): 62.37 (derivative) @ $23.68EDGAR
2026-04-214VanHimbergen Robert M — EVP and CFOGrant/award (A): 8.32 (derivative) @ $23.68EDGAR
2026-04-214Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, DirectorGrant/award (A): 119.38 (derivative) @ $23.68EDGAR
2026-04-074Modi Rajeev A. — SEE REMARKSGrant/award (A): 64.72 (derivative) @ $22.82EDGAR
2026-04-074de Brabander Ellen — SEE REMARKSGrant/award (A): 40,985 @ $0 · Tax withholding (F): 20,288 @ $23.12EDGAR
2026-04-074VanHimbergen Robert M — EVP and CFOGrant/award (A): 8.63 (derivative) @ $22.82EDGAR
2026-04-074Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, DirectorGrant/award (A): 123.88 (derivative) @ $22.82EDGAR
2026-04-024Anand Kapila K — DirectorGrant/award (A): 600.71 (derivative) @ $23.93EDGAR
2026-03-244Modi Rajeev A. — SEE REMARKSGrant/award (A): 61.59 (derivative) @ $23.98EDGAR

Recent 8-K events — Elanco Animal Health Inc

FiledFormItems reportedSource
2026-08-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-278-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-248-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-128-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-098-K?
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-038-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-06-268-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ELAN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →